EssilorLuxottica’s Annual Shareholders Meeting Approves All Resolutions, Reappoints Board

CHARENTON-LE-PONT, France—EssilorLuxottica held its annual shareholders meeting yesterday in Paris, the company announced, where shareholders approved all 34 resolutions submitted by the board of directors to the Ordinary and Extraordinary General Meeting. These included the distribution of a €3.95 dividend per share for the financial year 2023, the compensation policy applicable to the company’s executive corporate officers and the reappointment of all previous directors to the new board of directors. “On behalf of the board of directors, we would like to extend warm thanks to our shareholders for their continued support and trust," said Francesco Milleri, chairman and CEO, and Paul du Saillant, deputy CEO at EssilorLuxottica.

Nominations Are Now Open for VM’s 2024 Most Influential Women in Optical

NEW YORK—Women’s influence in optical is undeniable, and today more women are playing vital roles at all levels of our industry. In retailing, wholesaling, product design, manufacturing, distribution and vision care, talented women are shaping the direction of the companies and organizations they work for, and, in many cases, lead. This is why Vision Monday will once again be highlighting The Most Influential Women in Optical in our July-August issue, marking the 22nd year of our signature Special Report saluting women in the eyewear/eyecare industry.

Contact Lens Institute Issues Report on New and Returning Contact Lens Wearers

WASHINGTON, D.C.—The Contact Lens Institute (CLI) has published an in-depth report on everyday actions that the eyecare community can take to draw interest from potential and former contact lens wearers. Based on research with more than 1,000 vision-corrected adults segmented by glasses-only wearers, new contact lens wearers, and former contact lens wearers, “Beyond Vision: Behaviors to Attract New & Returning Contact Lens Wearers" is the latest offering from CLI’s See Tomorrow initiative. The 26-page document includes multiple infographics depicting high-value takeaways that can be used for staff training.

Nominate a Supportive Business Partner for the 20/20 Magazine and Vision Monday 2024 'Ultimate Partners' Program

NEW YORK—The readers of Vision Monday and 20/20 Magazine are being asked once again to share nominations for their Ultimate Partners. Now in it's fourth year, Jobson’s 2024 Ultimate Partners program allows readers to highlight their great business support partners and showcase their support. Open to all eyecare professionals, the program is looking to spotlight your most successful collaborations and celebrate the crucial support shared during both challenges and opportunities.

Bausch + Lomb Receives FDA Approval of Lumify Preservative Free Redness Reliever Eye Drops

VAUGHAN, Ontario—Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company, has announced the U.S. Food and Drug Administration (FDA) has approved Lumify Preservative Free redness reliever eye drops, an over-the-counter preservative-free eye drop with low-dose OTC brimonidine tartrate for the treatment of ocular redness due to minor eye irritations. “Lumify Preservative Free significantly reduces redness within one minute and lasts up to eight hours," said John Ferris, executive vice president, consumer, Bausch + Lomb.